Your Podsite trial is ending soon. Put the final touches on it with our tips on how to make a great podcast website.

Claim your custom domain name todayClaim your domain

S10: #093: Brain in a Dish: Personalizing Depression Treatment for Every Individual

27 minutes

In this episode we dive into mental health. More specifically, the treatment of major depressive disorder, also known as clinical depression. It is an area of tremendous need and one can be very well served through the solutions and approaches that are being developed and being made available to users around the world.

So, how big of a problem is severe depression? More than 300 million people of all ages suffer from depression, and at it’s worse, it can lead to suicide. Fewer than half of those suffering from depression are able to receive treatment due to limited resources, a lack of trained Health care providers, and of course, the social stigma that is still sadly associated with mental disorders.

There’s a host of treatment options for depression but the effectiveness of the treatments depend on the type of depression and its severity and, of course, each individual’s adherence and response. Some of the options include Psychotherapy, Psychoeducation and Support Groups, Medications, and Brain Stimulation Therapies. None of these options provide instant relief, and, like in the case of medications, it’s sometimes not known for many weeks if the treatment is effective at all. Antidepressants, for example, often take two to four weeks to begin having an effect, and up to 12 weeks to reach full effect.

With me today is Talia Cohen Solal, PhD, she’s the CEO and co-Founder of Genetika+. Genetika+ is developing a cellular and genetics-based platform to provide meaningful predictions of patient responses to antidepressants. Using biological, environmental and genetic data, they are developing a personalized solution for each patient to help them recover better and faster.


Today's Topics:

  • A quick background of Talia, her work and her on-going research focusing on mental health
  • The current statistics, stages of depression and how it impacts and individual and the society as a whole
  • The current treatment & medication available and how to measure their efficacy
  • How the trial and error approach does a disservice to patients
  • How the ‘Brain in a Dish' can accelerate patients getting onto therapies that produce the outcomes needed.


Links and Resources Mentioned:


Digital Health Today is made possible by the support of our sponsors. Thank you!

Learn more about your ad choices. Visit megaphone.fm/adchoices

More episodes from Digital Health Today 360 with Dan Kendall

S11: #110 Introducing the Host of the New Asia Pacific Edition: Tony Estrella

"In this episode, I'm excited to introduce you to yet another outstanding health innovation leader who is hosting another new show on Digital Health Today. His degrees are in engineering …

S11: #109 Introducing the Host of the new Digital Therapeutics Podcast: Eugene Borukhovich

In this episode, I have the pleasure of introducing you to one of the health sectors leading innovators, and probably one of the best known and, dare I say it, most loved, leaders I’ve had …

Coffee Talk: How Corporations Adapt in the Face of New Challenges

In this episode I welcome two executives from Bayer G4A. Bayer G4A has been a longtime sponsor of Digital Health Today. I caught up with Dominick Kennerson, Global Head G4A, Digital Health …

Coffee Talk: How Digital Health Startups Respond and Thrive in a Global Pandemic

Imagine this: You’re the founder of a digital health startup. You’ve been carefully selected and invited to participate in a brand new accelerator in …

S11: #108 - What the Clearance of Akili's EndeavorRX Means for the Company, Users and the Industry

If you’ve been tuned into nearly any news channel recently, you’ve probably seen the announcement by Akili about the clearance they announced on June 15 for their product EndeavorRX. It is …

Coffee Talk: How Innovative Companies can Partner with a Global Pharma Brand

For this special Coffee Talk, I invited Sophie Park, Chief Strategist for Bayer G4A Partnerships to discuss the opportunities for innovative companies to grow and partner with a global …

How you can listen to this podcast

You can listen to episodes right here on the website, or if you prefer, in a podcast app. Listening in an app makes it easier to keep track of what you’ve already heard, listen without using your data plan and many other conveniences.

Recommended apps
Start listening to S11: #110 Introducing the Host of the New Asia Pacific Edition: Tony Estrella
28:29
Start listening to S11: #110 Introducing the Host of the New Asia Pacific Edition: Tony Estrella
28:29